One year in: Extraordinary achievement, powerful momentum, and still a shortfall for the ACT-Accelerator

Workers in Abuja, Nigeria, scan a box containing vials of a COVID-19 vaccine procured through COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, March 2, 2021.
Workers in Abuja, Nigeria, scan a box containing vials of a COVID-19 vaccine procured through COVAX, the vaccines pillar of the Access to COVID-19 Tools (ACT) Accelerator, March 2, 2021. © UNICEF/UN0424213/Achirga Terngu

Read next

Two women looking at medical notes

Gates Foundation COVID-19 Response FAQ

The most frequently asked questions about the foundation’s COVID-19 response answered.
Two health workers wearing masks and goggles pointing at an x-ray on a computer monitor

Perspectives on the global pandemic response

The world has seen unprecedented challenges in the past months — as well as unprecedented collaboration.
Collaboration is the key to translating promising global health research into real-world solutions.

The Collaboratory: How sharing tools and technologies can shorten the timeline for global health R&D

Collaboration is the key to translating promising global health research into real-world solutions.
By Lynda Stuart Deputy Director, Vaccines & Human Immunology, Bill & Melinda Gates Foundation